Molecular therapies in Crohns disease: coming of age

© Springer-Verlag 2002 again, a subset of patients with Crohn’s disease can be maintained in remission [5], and that their fistulae apparently remain closed [6] if therapy is continued over 1 year. Immunosuppression leading to clinical benefits is, however, accompanied by sometimes severe side effects, which are apparently related to the very effect of the… (More)